Table 4 Adaptation
(note)
Approved Influenza Vaccines for Different Age Groups - United States, 2007-2008
season
Inactivated (Trivalent inactivated vaccine = TIV) (#)
Manufacturer: Sanofi Pasteur
Presentation:
Fluzone®
0.25 ml prefilled syringe
Thimerosal mercury content (mcg Hg/0.5-ml dose): 0
Age group: 6-35 months
No. of doses: 1 or 2 (*)
Route: Intramuscular (++)
Fluzone®
0.5 ml prefilled syringe
Thimerosal mercury content (mcg Hg/0.5-ml dose): 0
Age group: >= 36 months
No. of doses: 1 or 2 (*)
Route: Intramuscular (++)
Fluzone®
0.5 ml vial
Thimerosal mercury content (mcg Hg/0.5-ml dose): 0
Age group: >= 36 months
No. of doses: 1 or 2 (*)
Route: Intramuscular (++)
Fluzone®
5 ml multi-dose vial
Thimerosal mercury content (mcg Hg/0.5-ml dose): 25
Age group: >= 6 months
No. of doses: 1 or 2 (*)
Route: Intramuscular (++)
Manufacturer: Novartis Vaccine
Presentation: 5 ml multi-dose vial
Thimerosal mercury content (mcg Hg/0.5-ml dose): 24.5
Age group: >= 4 yrs
No. of doses: 1 or 2 (*)
Route: Intramuscular (++)
Manufacturer: GlaxoSmithKline
Presentation: 0.5 ml prefilled syringe
Thimerosal mercury content (mcg Hg/0.5-ml dose): <1.0
Age group: >= 18 yrs
No. of doses: 1
Route: Intramuscular (++)
Manufacturer: GlaxoSmithKline
Presentation: 5.0 mL multidose vial
Thimerosal mercury content (mcg Hg/0.5-ml dose): 25
Age group: >= 18 yrs
No. of doses: 1
Route: Intramuscular (++)
Live, attenuated influenza vaccine (LAIV)
FluMist™ (**)
Manufacturer: MedImmune
Presentation: 0.2 ml sprayer
Thimerosal mercury content (mcg Hg/0.5-ml dose): 0
Age group: 5-49 yrs (note)
No. of doses: 1 or 2
two doses administered at least 6 weeks apart are recommended for children aged 5-<9 yrs who are receiving influenza vaccine for the first time and those who received only 1 dose in their first year of vaccination should receive 2 doses in the following year.
Route: Intranasal
(++) For adults and older children, the recommended site of vaccination is the deltoid muscle. The preferred site for infants and young children is the anterolateral aspect of the thigh.
(*) two doses administered at least 1 month apart are recommended for children aged 6 months- <9 yrs who are receiving TIV for the first time and those who only received 1 dose in their first year of vaccination should receive 2 doses in the following year.
(#) Trivalent inactivated vaccine (TIV). A 0.5 mL dose contains 15 mcg each of A/Solomon Islands/3/2006 (H1N1)-like, A/Wisconsin/67/2005(H3N2)-like, and B/Malaysia/2506/2004-like antigens.
(**) FluMist dosage and storage requirements have changed for the 2007-2008 influenza season. FluMist is now shipped to end users at 35-46 deg F (2-8 deg C). LAIV should be stored at 35-46 deg F (2-8 deg C) upon receipt and should remain at that temperature until the expiration date is reached. The dose is 0.2 mL, divided equally between each nostril.
Note: This table's format was changed to make it more amenable to use on a PDA screen.